Dr Lorey K Smith
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
13 Scholarly works
0 Projects
HIGHLIGHTS
2023
Journal article
The therapeutic potential of targeting minimal residual disease in melanoma
DOI: 10.1002/ctm2.11972022
Journal article
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma
DOI: 10.1038/s41467-022-28705-x2022
Journal article
Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway
DOI: 10.1016/j.celrep.2022.1115712022
Journal article
Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
DOI: 10.1158/2159-8290.CD-21-05222021
Journal article
Phenotypic consequences of slc25a40-abcb1 fusions beyond drug resistance in high-grade serous ovarian cancer
DOI: 10.3390/cancers132256442021
Journal article
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
DOI: 10.1136/jitc-2021-0029952021
Journal article
Cdk4/6 inhibition reprograms mitochondrial metabolism in brafv600 melanoma via a p53 dependent pathway
DOI: 10.3390/cancers13030524
RECENT SCHOLARLY WORKS
2020
Journal article
Genome-wide RNAi screen for genes regulating glycolytic response to vemurafenib in BRAFV600 melanoma cells
DOI: 10.1038/s41597-020-00683-z2020
Conference Proceedings
Progression of BRAF mutant CNS metastases are associated with a transcriptional network bearing similarities with the innate PD-1 resistant signature (IPRES)
DOI: 10.1016/j.annonc.2020.08.12032016
Journal article
A Phenotypic High-Content Screening Assay to Identify Regulators of Membrane Protein Localization
DOI: 10.1089/adt.2016.733